Seegene 2024: Revenue +13%, Net Loss, Share Buyback & Dividends Maintained

Revenue KRW 414.3B (+13% YoY), operating loss KRW 16.5B (narrowed), net loss KRW 20.3B
Dividend per share KRW 800 (quarterly KRW 200), total dividend approx. KRW 36.9B (despite net loss)
Ongoing share buyback trust (672,740 shares left, KRW 30B); no cancellation plan
Asset impairments: Seegene USA fully impaired (KRW 55.5B), Brex impaired (KRW 3.5B), total KRW 28.2B
Technology-sharing initiative progressing (Microsoft, Springer Nature); new subsidiaries Brex and Pentaworks acquired
Equity method gain from Nanobelix: KRW 6.3B